Andlauer Healthcare Group Inc.
AND.TO · TSX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | CA$2,060 | CA$1,571 | CA$1,656 | CA$1,536 |
| - Cash | CA$59 | CA$44 | CA$40 | CA$36 |
| + Debt | CA$178 | CA$183 | CA$181 | CA$159 |
| Enterprise Value | CA$2,179 | CA$1,709 | CA$1,797 | CA$1,659 |
| Revenue | CA$157 | CA$166 | CA$168 | CA$160 |
| % Growth | -5.7% | -1.3% | 5.4% | – |
| Gross Profit | CA$36 | CA$37 | CA$40 | CA$37 |
| % Margin | 22.9% | 22.1% | 23.5% | 23.3% |
| EBITDA | CA$38 | CA$45 | CA$44 | CA$42 |
| % Margin | 24.5% | 27.3% | 26% | 26.2% |
| Net Income | CA$13 | CA$20 | CA$18 | CA$16 |
| % Margin | 8.6% | 12.2% | 10.4% | 10.2% |
| EPS Diluted | 0.34 | 0.5 | 0.44 | 0.41 |
| % Growth | -32% | 13.6% | 7.3% | – |
| Operating Cash Flow | CA$36 | CA$33 | CA$23 | CA$31 |
| Capital Expenditures | -CA$5 | -CA$7 | -CA$5 | -CA$4 |
| Free Cash Flow | CA$31 | CA$26 | CA$18 | CA$27 |